Alexey V. Dimov

Dr. Alexey V. Dimov

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2022 in Journal of Neuroimaging
Verified
Journal Article
Closed access
ADAlexey V. Dimov
Alexey V. Dimov
TNThanh Nguyen
Thanh Nguyen
KGKelly M. Gillen
Kelly M. Gillen
MMMelanie Marcille
Melanie Marcille
PSPascal Spincemaille
Pascal Spincemaille
YWYi Wang
Yi Wang

19 January 2022 in Neurology Neuroimmunology & Neuroinflammation
Verified
Journal Article
Open access
PDF file
NZNicole Zinger
Nicole Zinger
GPGerald Ponath
Gerald Ponath
ESElizabeth Sweeney
Elizabeth Sweeney
TNThanh Nguyen
Thanh Nguyen
CLChih Hung Lo
Chih Hung Lo
SGSusan A. Gauthier
Susan A. Gauthier
Background and Objectives To determine the effects of dimethyl fumarate (DMF) and glatiramer acetate on iron content in chronic active lesions in patients with multiple sclerosis (MS) and in human microglia in vitro. Methods This was a retrospective observational study of 34 patients with relapsing-remitting MS and clinically isolated syndrome treated with DMF or glatiramer acetate. Patients had lesions with hyperintense rims on quantitative susceptibility mapping, were treated with DMF or glatiramer acetate (GA), and had a minimum of 2 on-treatment scans. Changes in susceptibility in rim lesions were compared among treatment groups in a linear mixed effects model. In a separate in vitro study, induced pluripotent stem cell–derived human microglia were treated with DMF or GA, and treatment-induced changes in iron content and activation state of microglia were compared. Results Rim lesions in patients treated with DMF had on average a 2.77-unit reduction in susceptibility per year over rim lesions in patients treated with GA (bootstrapped 95% CI −5.87 to −0.01), holding all other variables constant. Moreover, DMF but not GA reduced inflammatory activation and concomitantly iron content in human microglia in vitro. Discussion Together, our data indicate that DMF-induced reduction of susceptibility in MS lesions is associated with a decreased activation state in microglial cells. We have demonstrated that a specific disease modifying therapy, DMF, decreases glial activity in chronic active lesions. Susceptibility changes in rim lesions provide an in vivo biomarker for the effect of DMF on microglial activity. Classification of Evidence This study provided Class III evidence that DMF is superior to GA in the presence of iron as a marker of inflammation as measured by MRI quantitative susceptibility mapping.

14 December 2021 in Journal of Neuroimaging
Verified
Journal Article
Closed access
PDF file
KLKailyn R. Li
Kailyn R. Li
JAJosue Avecillas‐Chasin
Josue Avecillas‐Chasin
TNThanh D. Nguyen
Thanh D. Nguyen
KGKelly M. Gillen
Kelly M. Gillen
ADAlexey V. Dimov
Alexey V. Dimov
ASAlexander Shtilbans
Alexander Shtilbans

14 June 2022 in Tomography
Verified
Journal Article
Open access
PDF file
ADAlexey V. Dimov
Alexey V. Dimov
KGKelly M. Gillen
Kelly M. Gillen
TNThanh Nguyen
Thanh Nguyen
JKJerry Kang
Jerry Kang
RSRia Dang Sharma
Ria Dang Sharma
YWYi Wang
Yi Wang
Quantitative susceptibility mapping (QSM) facilitates mapping of the bulk magnetic susceptibility of tissue from the phase of complex gradient echo (GRE) MRI data. QSM phase processing combined with an R2* model of magnitude of multiecho gradient echo data (R2*QSM) allows separation of dia- and para-magnetic components (e.g., myelin and iron) that contribute constructively to R2* value but destructively to the QSM value of a voxel. This R2*QSM technique is validated against quantitative histology—optical density of myelin basic protein and Perls’ iron histological stains of rim and core of 10 ex vivo multiple sclerosis lesions, as well as neighboring normal appearing white matter. We found that R2*QSM source maps are in good qualitative agreement with histology, e.g., showing increased iron concentration at the edge of the rim+ lesions and myelin loss in the lesions’ core. Furthermore, our results indicate statistically significant correlation between paramagnetic and diamagnetic tissue components estimated with R2*QSM and optical densities of Perls’ and MPB stains. These findings provide direct support for the use of R2*QSM magnetic source separation based solely on GRE complex data to characterize MS lesion composition.

7 February 2023 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
ADAlexey V. Dimov
Alexey V. Dimov
JLJiahao Li
Jiahao Li
TNThanh Nguyen
Thanh Nguyen
Alexandra Grace RobertsAlexandra Grace Roberts
Alexandra Grace Roberts
PSPascal Spincemaille
Pascal Spincemaille
YWYi Wang
Yi Wang

31 October 2021 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PDF file
JCJunghun Cho
Junghun Cho
JZJinwei Zhang
Jinwei Zhang
PSPascal Spincemaille
Pascal Spincemaille
HZHang Zhang
Hang Zhang
SHSimon Hubertus
Simon Hubertus
YWYi Wang
Yi Wang